Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $122 | $207 | $207 | $207 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $0 |
| Enterprise Value | $121 | $207 | $208 | $207 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$11 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$17 | -$13 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.56 | -0.44 | -0.029 | -0.005 |
| % Growth | -27.3% | -1,427.8% | -512.8% | – |
| Operating Cash Flow | -$5 | -$4 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$5 | -$4 | -$0 | -$0 |